Diabetes is not classified as a vascular disease, but the connection between the two is so tight that several major medical organizations treat diabetes as a cardiovascular risk equivalent. That means having type 2 diabetes, even without a history of heart attack or stroke, puts you in roughly the same risk category as someone who already has established blood vessel disease. The American Association of Clinical Endocrinologists explicitly categorizes type 2 diabetes this way, and European cardiology guidelines skip standard population risk calculators entirely for people with diabetes, instead automatically placing them in moderate, high, or very high cardiovascular risk categories based on how long they’ve had the disease and whether organ damage is already present.
So while diabetes is formally a metabolic disease, defined by how the body handles blood sugar, its most dangerous consequences play out in the blood vessels. Understanding why helps explain the treatments your doctor recommends and the screenings they order.
How Diabetes Damages Blood Vessels
Persistently elevated blood sugar sets off a chain of events inside artery walls. Glucose molecules latch onto proteins through a chemical process that eventually produces compounds called advanced glycation end-products, or AGEs. These AGEs accumulate in vessel walls and form rigid cross-links with collagen and elastin, the fibers that give arteries their flexibility. The result is stiffer, less elastic blood vessels that can’t expand and contract normally with each heartbeat.
Beyond structural stiffening, AGEs also trigger inflammation. They activate cells lining the arteries, smooth muscle cells deeper in the vessel wall, and immune cells called macrophages. All three cell types play direct roles in building arterial plaques. AGEs simultaneously increase oxidative stress, which further accelerates plaque formation. This is why atherosclerosis, the buildup of fatty deposits inside arteries, progresses faster and more aggressively in people with diabetes than in the general population.
Insulin resistance adds another layer of damage. When muscles become resistant to insulin’s signal, the body compensates by pumping out more insulin. High circulating insulin itself promotes arterial disease. Meanwhile, excess abdominal fat floods the liver with fatty acids, driving up triglyceride-rich particles in the blood while lowering protective HDL cholesterol. The small, dense LDL particles typical of type 2 diabetes are especially prone to oxidation, which makes them more inflammatory and more likely to lodge in artery walls.
Fat tissue also releases inflammatory signaling molecules that act directly on blood vessel cells and prompt the liver to produce clotting factors. This creates a prothrombotic state where blood clots form more easily, raising the risk of heart attacks and strokes on top of the plaque burden already building inside the arteries.
Large Vessel Complications
The damage to large arteries, called macrovascular disease, is the leading cause of death in people with type 2 diabetes. Heart attack, stroke, and peripheral artery disease are all significantly more common. In the landmark UK Prospective Diabetes Study, intensive blood sugar control reduced heart attacks by 16%, and a subgroup of overweight patients treated with metformin saw a 39% reduction in heart attacks. Those numbers highlight both the connection between glucose control and vascular outcomes and the difficulty of fully eliminating the excess risk.
What makes macrovascular disease tricky in diabetes is that blood sugar is only one of several simultaneous drivers. Abnormal cholesterol, high blood pressure, inflammation, and clotting abnormalities all converge at once. Targeting glucose alone doesn’t solve the problem, which is why modern treatment guidelines emphasize managing all of these risk factors together rather than focusing on blood sugar in isolation.
Peripheral Artery Disease in Diabetes
Peripheral artery disease, or PAD, affects about 17% of people with type 2 diabetes, a rate consistent across international studies. PAD narrows the arteries supplying the legs and feet, causing pain with walking, slow-healing wounds, and in severe cases, tissue loss that can lead to amputation.
Diagnosis typically involves measuring the ankle-brachial index (ABI), which compares blood pressure at the ankle to blood pressure in the arm. In diabetes, though, the test has a catch: arterial calcification from AGE-related stiffening can falsely inflate the reading. An ABI of 1.30 or higher, which in a non-diabetic person might look normal or even healthy, actually signals calcified arteries and is considered diagnostic for PAD in type 2 diabetes. This means standard screening can miss the disease if clinicians don’t account for how diabetes changes the vessels.
Small Vessel Damage
While large vessel disease gets the most attention because of heart attacks and strokes, diabetes also destroys the tiny blood vessels that supply the eyes, kidneys, and nerves. These microvascular complications, including diabetic retinopathy, kidney disease, and neuropathy, are driven more directly by blood sugar levels than macrovascular disease is. Keeping hemoglobin A1c (a measure of average blood sugar over two to three months) between 6.0% and 7.0% is the target for people with mild or no complications and a life expectancy beyond 10 years. For those with advanced complications or shorter life expectancy, targets are relaxed to 8.0% to 9.0%, reflecting the diminishing benefit and increasing risk of aggressive glucose lowering in that group.
The distinction matters practically. If you’ve been recently diagnosed and have no complications, tighter blood sugar control offers real protection for your small vessels. If you’ve lived with diabetes for decades and already have significant damage, the calculus shifts toward preventing hypoglycemia and managing symptoms.
How Vascular Risk Is Managed
Because diabetes carries such high vascular risk, treatment guidelines don’t wait for signs of artery disease before intervening. The 2026 ACC/AHA guidelines recommend that all adults aged 40 to 75 with diabetes take a moderate-intensity statin, regardless of their estimated 10-year cardiovascular risk score. The goal is to lower LDL cholesterol by at least 30% to 49%.
If you have diabetes plus additional risk factors like high blood pressure, smoking, kidney disease, or a family history of early heart disease, guidelines recommend escalating to high-intensity statin therapy, targeting at least a 50% reduction in LDL cholesterol. For people who can’t tolerate statins, alternative cholesterol-lowering medications are recommended rather than simply skipping treatment.
People with diabetes who also have persistently elevated triglycerides (a type of blood fat) despite statin therapy may benefit from additional medication to bring those levels down, further reducing cardiovascular events.
Blood sugar management remains important, but it’s one piece of a larger strategy. Blood pressure control, cholesterol management, weight loss, physical activity, and smoking cessation all contribute to slowing or preventing vascular damage. The most effective approach treats diabetes as what it functionally is: a condition that, left unchecked, becomes a vascular disease.